Conference Coverage
Conference Coverage
VIDEO: What’s new with HER2-neu inhibition
MIAMI BEACH – For women with HER2-positive disease, neoadjuvant therapy with trastuzumab (Herceptin) was and is a game changer, improving...
Conference Coverage
VIDEO: Vaccines, combination therapy hold most promise for optimizing immunotherapy in breast cancer
MIAMI BEACH – Although typically not as immunogenic as melanoma or lung cancer, breast cancer can respond to immunotherapy.
Conference Coverage
VIDEO: Registry studies reflect real patients in the real world
MIAMI BEACH – Studies using data from prospective registries provide valuable insights for investigators into diseases of real patients in real-...
Conference Coverage
VIDEO: HER2+ patients may do fine with local therapies alone
MIAMI BEACH – Unquestionably, the advent of human epidermal growth factor receptor-2 (HER2) inhibitors has dramatically improved long-term...
Conference Coverage
HT use associated with lower postmenopausal coronary artery calcium scores
Could the lower postmenopausal coronary artery calcium scores seen in HT users be linked to lower all-cause mortality?
Conference Coverage
VIDEO: Future therapies look promising for HER2 treatment-resistant breast cancer patients
Several antibody-drug conjugates and additional types of agents are showing promise for HER2 treatment-resistant breast cancer.
Conference Coverage
VIDEO: Resistance to endocrine therapy a moving target
MIAMI BEACH – Dr. William J. Gradishar discusses strategies for combating resistance to endocrine ablative therapy in a video interview.
Conference Coverage
Ask patients about sexual function at first visit
LAS VEGAS – Addressing the topic of sexual health with patients can prove challenging, especially if the patient is experiencing difficulty in...
Conference Coverage
Cervicovaginal microbiota correlates with preterm birth rate
LAS VEGAS – Some cervicovaginal microbiota increase the risk of preterm birth, while others are protective.
Conference Coverage
Long-term peanut sublingual immunotherapy found safe
ATLANTA – Peanut sublingual immunotherapy induces clinically significant desensitization in the majority of subjects.
Conference Coverage
VIDEO: Despite promises of abstinence, isotretinoin-exposed pregnancies still occur
ORLANDO – Pregnancy prevention remains a challenge when prescribing isotretinoin to women of childbearing years with acne.